Universal Health Services stock reports 8.3 percent Q2 growth

Published on 10/05/2026 at 19:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Universal Health stock posted USD 4.64 billion in Q2 revenue, up 8.3 percent year over year. Analysts set a USD 204.94 average target across 18 firms.

Isometrische Grafik einer Behandlungskette von Aufnahme bis Entlassung — Isometrische 3D-Grafik zeigt Behandlungsprozess passend zu Universal Health, Aktie ISIN US9139031002, von Aufnahme bis Entlassung, Illustration mit AI erstellt.

Universal Health Services stock (ISIN US9139031002) was trading at USD 176.99 on the NYSE on October 5, 2026 at 1:52 p.m. ET, up 0.72 percent from the previous close. The latest reported quarter delivered revenue of USD 4.64 billion, an 8.3 percent year-over-year increase, keeping operating performance at the center of the investment debate.

Revenue growth meets earnings scrutiny

According to MarketBeat on September 24, 2026, Universal Health Services reported USD 5.98 in quarterly adjusted EPS for Q2 2026, compared with USD 5.35 in the same quarter of 2025. The result exceeded the USD 5.94 consensus estimate by USD 0.04, while revenue of USD 4.64 billion exceeded the USD 4.58 billion estimate.

The company also reported USD 364.59 million in consolidated net income for Q2 2026, equal to an 8.0 percent net profit margin. Revenue increased from USD 4.50 billion in Q1 2026 to USD 4.64 billion in Q2, while diluted EPS rose from USD 5.65 to USD 5.98, giving the latest quarter a sequential earnings lift.

Analysts keep a cautious balance

As Investing.com reported on October 2, 2026, Cantor Fitzgerald reiterated a Neutral rating and a USD 194.00 price target. That target lies 9.6 percent above the October 5 trading price, while the analyst cited the importance of the second-half 2026 EBITDA ramp.

MarketBeat reported on September 26, 2026, that 18 research firms covered the stock, with 12 Hold ratings and six Buy ratings. The average 12-month target was USD 204.94, which stood 15.8 percent above the NYSE price, making the consensus more constructive than the individual Neutral stance from Cantor Fitzgerald.

Stock sits below its yearly high

Universal Health Services was trading 28.1 percent below its 52-week high of USD 246.33 and 26.3 percent above its 52-week low of USD 140.08 on October 5, 2026. The USD 10.7 billion market capitalization and 141,458-share volume show a mid-cap healthcare stock with a valuation debate tied closely to earnings delivery.

The company operates acute care hospitals and behavioral health facilities in the United States, and its Q2 revenue growth contrasts with the market's attention to margins and second-half execution. For investors, the key comparison is therefore clear: revenue rose 8.3 percent year over year, while the consensus target remains USD 27.95 above the current trading price.

Universal Health Services stock trades at USD 176.99

Universal Health Services stock was trading at USD 176.99 on the NYSE on October 5, 2026 at 1:52 p.m. ET, with a daily gain of 0.72 percent and a 52-week range of USD 140.08 to USD 246.33.